Showing results (141-150 of 231) with videos related to

Sort By:
Pageof 24
The New England Journal of Medicine|September 13, 2018
Phase 2 Trial of Selective Tyrosine Kinase 2 Inhibition in PsoriasisKim Papp, Kenneth Gordon, Diamant Thaçi, et al.
American Journal of Clinical Dermatology|November 13, 2018
Improvement in Patient-Reported Outcomes (Dermatology Life Quality Index and the Psoriasis Symptoms and Signs Diary) with Guselkumab in Moderate-to-Severe Plaque Psoriasis: Results from the Phase III VOYAGE 1 and VOYAGE 2 StudiesApril W Armstrong, Kristian Reich, Peter Foley, et al.
Drug Safety|June 2, 2021
Signal Detection and Methodological Limitations in a Real-World Registry: Learnings from the Evaluation of Long-Term Safety Analyses in PSOLARRobert Bissonnette, Alice B Gottlieb, Richard G Langley, et al.
JAMA|August 25, 2011
Association between biologic therapies for chronic plaque psoriasis and cardiovascular events: a meta-analysis of randomized controlled trialsCaitriona Ryan, Craig L Leonardi, James G Krueger, et al.
Dermatology and Therapy|December 4, 2012
A Delphi Consensus Approach to Challenging Case Scenarios in Moderate-to-Severe Psoriasis: Part 2Bruce E Strober, Jennifer Clay Cather, David Cohen, et al.
Acta Dermato-Venereologica|February 3, 2016
Effects of Apremilast on Pruritus and Skin Discomfort/Pain Correlate With Improvements in Quality of Life in Patients With Moderate to Severe Plaque PsoriasisJeffrey M Sobell, Peter Foley, Darryl Toth, et al.
The Journal of Dermatological Treatment|May 11, 2016
Adherence to topical therapies in actinic keratosis: A literature reviewPeter Foley, Eggert Stockfleth, Ketty Peris, et al.
The Australasian Journal of Dermatology|July 13, 2016
The Australasian Psoriasis Collaboration view on methotrexate for psoriasis in the Australasian settingMarius Rademaker, Monisha Gupta, Megan Andrews, et al.
ACS Biomaterials Science & Engineering|October 4, 2023
Layer-by-Layer Analysis of <i>In Vitro</i> Skin ModelsElizabeth Footner, Kate Firipis, Emily Liu, et al.
Dermatology and Therapy|December 4, 2012
A Delphi Consensus Approach to Challenging Case Scenarios in Moderate-to-Severe Psoriasis: Part 1Bruce E Strober, Jennifer Clay Cather, David Cohen, et al.
Pageof 24